TD Waterhouse Canada’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

TD Waterhouse Canada’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,211	Closed	-$341K	–	1792
2022 Q2	$341K	Sell	6,211 -246	-4%	-$10.3K	﹤0.01%	608
2022 Q1	$372K	Sell	6,457 -211	-3%	-$9.27K	﹤0.01%	635
2021 Q4	$389K	Buy	+6,668	New	+$316K	﹤0.01%	662

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

TD Waterhouse Canada's XPH Position: Q3 2022 in Review

TD Waterhouse Canada sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2022, closing a stake of 6,211 shares — an estimated $341K sold.

TD Waterhouse Canada first reported a position in XPH in Q4 2021 and held it in 3 quarters. The position peaked at $389K in Q4 2021. 66 funds tracked by Wall St. Rank hold XPH as of Q3 2022.

TD Waterhouse Canada reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
TD Waterhouse Canada sold 6,211 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2022, an estimated $341K.
TD Waterhouse Canada first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2021 and held it in 3 quarters.
TD Waterhouse Canada's State Street SPDR S&P Pharmaceuticals ETF position peaked at $389K in Q4 2021.
66 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2022.

Based on TD Waterhouse Canada's 13F filing for Q3 2022, filed 13 Nov 2023.